Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 29, 2016 Filed Mar 3, 2016 00:28 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 9,017 | $38.94 | $351,094.93 |
DisclosureSEC source: 0001179110-16-020737 · edgar.xml · nonDerivative · entry 3 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,167 Read SEC document |
| February 29, 2016 Filed Mar 3, 2016 00:28 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 100 | $38.94 | $3,893.50 |
DisclosureSEC source: 0001179110-16-020737 · edgar.xml · nonDerivative · entry 2 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,184 Read SEC document |
| February 29, 2016 Filed Mar 3, 2016 00:28 UTC |
Contreras JaimeSenior Vice President
|
Tax withholdingCommon shares without par value | 6,283 | $39.52 | $248,304.16 |
DisclosureSEC source: 0001179110-16-020737 · edgar.xml · nonDerivative · entry 1 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,284 Read SEC document |
| February 29, 2016 Filed Mar 3, 2016 00:28 UTC |
Fussell Stephen RExecutive Vice President
|
SaleCommon shares without par value | 1,340 | $39.26 | $52,609.74 |
DisclosureSEC source: 0001179110-16-020738 · edgar.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,967 Read SEC document |
| February 29, 2016 Filed Mar 3, 2016 00:28 UTC |
Fussell Stephen RExecutive Vice President
|
SaleCommon shares without par value | 62 | $39.27 | $2,434.43 |
DisclosureSEC source: 0001179110-16-020738 · edgar.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,307 Read SEC document |
| February 29, 2016 Filed Mar 3, 2016 00:28 UTC |
Fussell Stephen RExecutive Vice President
|
Tax withholdingCommon shares without par value | 10,039 | $39.52 | $396,741.28 |
DisclosureSEC source: 0001179110-16-020738 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,369 Read SEC document |
| February 29, 2016 Filed Mar 3, 2016 00:30 UTC |
NATH DEEPAK S.Senior Vice President
|
SaleCommon shares without par value | 100 | $39.28 | $3,927.50 |
DisclosureSEC source: 0001179110-16-020739 · edgar.xml · nonDerivative · entry 3 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,571 Read SEC document |
| February 29, 2016 Filed Mar 3, 2016 00:30 UTC |
NATH DEEPAK S.Senior Vice President
|
SaleCommon shares without par value | 693 | $39.27 | $27,214.80 |
DisclosureSEC source: 0001179110-16-020739 · edgar.xml · nonDerivative · entry 2 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,671 Read SEC document |
| February 29, 2016 Filed Mar 3, 2016 00:30 UTC |
NATH DEEPAK S.Senior Vice President
|
Tax withholdingCommon shares without par value | 2,040 | $39.52 | $80,620.80 |
DisclosureSEC source: 0001179110-16-020739 · edgar.xml · nonDerivative · entry 1 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,364 Read SEC document |
| February 29, 2016 Filed Mar 3, 2016 00:32 UTC |
Ford Robert BExecutive Vice President
|
SaleCommon shares without par value | 1,306 | $39.29 | $51,306.21 |
DisclosureSEC source: 0001179110-16-020740 · edgar.xml · nonDerivative · entry 3 Ford Robert B · CIK 0001612571 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,789 Read SEC document |
| February 29, 2016 Filed Mar 3, 2016 00:32 UTC |
Ford Robert BExecutive Vice President
|
SaleCommon shares without par value | 400 | $39.28 | $15,713.60 |
DisclosureSEC source: 0001179110-16-020740 · edgar.xml · nonDerivative · entry 2 Ford Robert B · CIK 0001612571 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,095 Read SEC document |
| February 29, 2016 Filed Mar 3, 2016 00:32 UTC |
Ford Robert BExecutive Vice President
|
Tax withholdingCommon shares without par value | 4,483 | $39.52 | $177,168.16 |
DisclosureSEC source: 0001179110-16-020740 · edgar.xml · nonDerivative · entry 1 Ford Robert B · CIK 0001612571 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,495 Read SEC document |
| February 22, 2016 Filed Feb 23, 2016 22:38 UTC |
Watkin JaredSenior Vice President
|
SaleCommon shares without par value | 154 | $39.09 | $6,020.48 |
DisclosureSEC source: 0001179110-16-019885 · edgar.xml · nonDerivative · entry 5 Watkin Jared · CIK 0001645118 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,535 Read SEC document |
| February 22, 2016 Filed Feb 23, 2016 22:38 UTC |
Watkin JaredSenior Vice President
|
SaleCommon shares without par value | 400 | $39.10 | $15,638.00 |
DisclosureSEC source: 0001179110-16-019885 · edgar.xml · nonDerivative · entry 4 Watkin Jared · CIK 0001645118 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,689 Read SEC document |
| February 22, 2016 Filed Feb 23, 2016 22:44 UTC |
NATH DEEPAK S.Senior Vice President
|
SaleCommon shares without par value | 300 | $39.10 | $11,728.50 |
DisclosureSEC source: 0001179110-16-019895 · edgar.xml · nonDerivative · entry 4 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,404 Read SEC document |
| February 22, 2016 Filed Feb 23, 2016 22:44 UTC |
NATH DEEPAK S.Senior Vice President
|
SaleCommon shares without par value | 19 | $39.09 | $742.79 |
DisclosureSEC source: 0001179110-16-019895 · edgar.xml · nonDerivative · entry 3 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,704 Read SEC document |
| February 21, 2016 Filed Feb 23, 2016 22:38 UTC |
Watkin JaredSenior Vice President
|
Tax withholdingCommon shares without par value | 683 | $38.53 | $26,315.99 |
DisclosureSEC source: 0001179110-16-019885 · edgar.xml · nonDerivative · entry 3 Watkin Jared · CIK 0001645118 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,089 Read SEC document |
| February 21, 2016 Filed Feb 23, 2016 22:44 UTC |
NATH DEEPAK S.Senior Vice President
|
Tax withholdingCommon shares without par value | 819 | $38.53 | $31,556.07 |
DisclosureSEC source: 0001179110-16-019895 · edgar.xml · nonDerivative · entry 2 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,723 Read SEC document |
| February 21, 2016 Filed Feb 23, 2016 22:47 UTC |
BIRD ROGERSenior Vice President
|
Tax withholdingCommon shares without par value | 767 | $38.53 | $29,552.51 |
DisclosureSEC source: 0001179110-16-019898 · edgar.xml · nonDerivative · entry 2 BIRD ROGER · CIK 0001635313 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,513 Read SEC document |
| February 20, 2016 Filed Feb 23, 2016 22:38 UTC |
Watkin JaredSenior Vice President
|
Tax withholdingCommon shares without par value | 743 | $38.53 | $28,627.79 |
DisclosureSEC source: 0001179110-16-019885 · edgar.xml · nonDerivative · entry 2 Watkin Jared · CIK 0001645118 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,772 Read SEC document |
| February 20, 2016 Filed Feb 23, 2016 22:45 UTC |
LANE ANDREW HSenior Vice President
|
Tax withholdingCommon shares without par value | 605 | $38.53 | $23,310.65 |
DisclosureSEC source: 0001179110-16-019897 · edgar.xml · nonDerivative · entry 1 LANE ANDREW H · CIK 0001643735 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,703 Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:39 UTC |
Salvadori Daniel Gesua SiveSenior Vice President
|
GrantOption (right to buy) · Derivative | 213,470 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019887 · edgar.xml · derivative · entry 2 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,470 Underlying: Common shares · 213,470 shares Expires 2026-02-18 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 71,157 on 02/19/2017, 71,156 on 02/19/2018, and 71,157 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:39 UTC |
Salvadori Daniel Gesua SiveSenior Vice President
|
GrantCommon shares without par value | 24,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019887 · edgar.xml · nonDerivative · entry 1 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,322 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:38 UTC |
Watkin JaredSenior Vice President
|
GrantOption (right to buy) · Derivative | 174,657 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019885 · edgar.xml · derivative · entry 7 Watkin Jared · CIK 0001645118 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,657 Underlying: Common shares · 174,657 shares Expires 2026-02-18 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 58,219 on 02/19/2017, 58,219 on 02/19/2018, and 58,219 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:38 UTC |
Watkin JaredSenior Vice President
|
GrantCommon shares without par value | 19,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019885 · edgar.xml · nonDerivative · entry 1 Watkin Jared · CIK 0001645118 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,515 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:40 UTC |
Pavee Jean-YvesSenior Vice President
|
GrantOption (right to buy) · Derivative | 194,063 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019888 · edgar.xml · derivative · entry 1 Pavee Jean-Yves · CIK 0001580217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,063 Underlying: Common shares · 194,063 shares Expires 2026-02-18 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 64,688 on 02/19/2017, 64,687 on 02/19/2018, and 64,688 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:43 UTC |
Warmuth Michael JExecutive Vice President
|
GrantOption (right to buy) · Derivative | 313,926 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019893 · edgar.xml · derivative · entry 1 Warmuth Michael J · CIK 0001452290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,926 Underlying: Common shares · 313,926 shares Expires 2026-02-18 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 104,642 on 02/19/2017, 104,642 on 02/19/2018, and 104,642 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:44 UTC |
NATH DEEPAK S.Senior Vice President
|
GrantOption (right to buy) · Derivative | 145,547 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019895 · edgar.xml · derivative · entry 5 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,547 Underlying: Common shares · 145,547 shares Expires 2026-02-18 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 48,516 on 02/19/2017, 48,515 on 02/19/2018, and 48,516 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:44 UTC |
NATH DEEPAK S.Senior Vice President
|
GrantCommon shares without par value | 16,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019895 · edgar.xml · nonDerivative · entry 1 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,542 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:45 UTC |
LANE ANDREW HSenior Vice President
|
GrantOption (right to buy) · Derivative | 174,657 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019897 · edgar.xml · derivative · entry 2 LANE ANDREW H · CIK 0001643735 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,657 Underlying: Common shares · 174,657 shares Expires 2026-02-18 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 58,219 on 02/19/2017, 58,219 on 02/19/2018, and 58,219 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:47 UTC |
BIRD ROGERSenior Vice President
|
GrantOption (right to buy) · Derivative | 145,547 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019898 · edgar.xml · derivative · entry 3 BIRD ROGER · CIK 0001635313 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,547 Underlying: Common shares · 145,547 shares Expires 2026-02-18 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 48,516 on 02/19/2017, 48,515 on 02/19/2018, and 48,516 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:47 UTC |
BIRD ROGERSenior Vice President
|
GrantCommon shares without par value | 16,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019898 · edgar.xml · nonDerivative · entry 1 BIRD ROGER · CIK 0001635313 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,280 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:47 UTC |
Mason Heather LExecutive Vice President
|
GrantOption (right to buy) · Derivative | 214,041 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019900 · edgar.xml · derivative · entry 2 Mason Heather L · CIK 0001432601 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,041 Underlying: Common shares · 214,041 shares Expires 2026-02-18 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 71,347 on 02/19/2017, 71,347 on 02/19/2018, and 71,347 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:47 UTC |
Mason Heather LExecutive Vice President
|
GrantCommon shares without par value | 24,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019900 · edgar.xml · nonDerivative · entry 1 Mason Heather L · CIK 0001432601 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,289 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:47 UTC |
Ford Robert BExecutive Vice President
|
GrantOption (right to buy) · Derivative | 285,388 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019902 · edgar.xml · derivative · entry 3 Ford Robert B · CIK 0001612571 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,388 Underlying: Common shares · 285,388 shares Expires 2026-02-18 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 95,130 on 02/19/2017, 95,129 on 02/19/2018, and 95,129 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:47 UTC |
Ford Robert BExecutive Vice President
|
GrantCommon shares without par value | 32,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019902 · edgar.xml · nonDerivative · entry 1 Ford Robert B · CIK 0001612571 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,978 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:48 UTC |
ASHLEY RICHARD WExecutive Vice President
|
GrantOption (right to buy) · Derivative | 313,926 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019904 · edgar.xml · derivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,926 Underlying: Common shares · 313,926 shares Expires 2026-02-18 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 104,642 on 02/19/2017, 104,642 on 02/19/2018, and 104,642 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:48 UTC |
ASHLEY RICHARD WExecutive Vice President
|
GrantCommon shares without par value | 35,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019904 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,690 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:48 UTC |
ALLEN HUBERT LExecutive Vice President
|
GrantOption (right to buy) · Derivative | 285,388 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019905 · edgar.xml · derivative · entry 2 ALLEN HUBERT L · CIK 0001565916 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,388 Underlying: Common shares · 285,388 shares Expires 2026-02-18 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 95,130 on 02/19/2017, 95,129 on 02/19/2018, and 95,129 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:48 UTC |
ALLEN HUBERT LExecutive Vice President
|
GrantCommon shares without par value | 32,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019905 · edgar.xml · nonDerivative · entry 1 ALLEN HUBERT L · CIK 0001565916 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,720 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:01 UTC |
FRINZI THOMAS GSenior Vice President
|
GrantOption (right to buy) · Derivative | 174,657 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019912 · edgar.xml · derivative · entry 2 FRINZI THOMAS G · CIK 0001663458 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,657 Underlying: Common shares · 174,657 shares Expires 2026-02-18 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 58,219 on 02/19/2017, 58,219 on 02/19/2018, and 58,219 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:01 UTC |
FRINZI THOMAS GSenior Vice President
|
GrantCommon shares without par value | 19,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019912 · edgar.xml · nonDerivative · entry 1 FRINZI THOMAS G · CIK 0001663458 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,921 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:01 UTC |
Contreras JaimeSenior Vice President
|
GrantOption (right to buy) · Derivative | 242,579 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019915 · edgar.xml · derivative · entry 6 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,579 Underlying: Common shares · 242,579 shares Expires 2026-02-18 F6 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 80,860 on 02/19/2017, 80,859 on 02/19/2018, and 80,860 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:01 UTC |
Contreras JaimeSenior Vice President
|
GrantCommon shares without par value | 27,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019915 · edgar.xml · nonDerivative · entry 1 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,567 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:02 UTC |
CAPEK JOHN MExecutive Vice President
|
GrantOption (right to buy) · Derivative | 214,041 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019916 · edgar.xml · derivative · entry 2 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,041 Underlying: Common shares · 214,041 shares Expires 2026-02-18 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 71,347 on 02/19/2017, 71,347 on 02/19/2018, and 71,347 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:02 UTC |
CAPEK JOHN MExecutive Vice President
|
GrantCommon shares without par value | 24,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019916 · edgar.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,504 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:08 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 485,159 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019924 · edgar.xml · derivative · entry 8 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485,159 Underlying: Common shares · 485,159 shares Expires 2026-02-18 F7 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 161,720 on 02/19/2017, 161,719 on 02/19/2018, and 161,720 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:08 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantCommon shares without par value | 55,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019924 · edgar.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 402,590 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:02 UTC |
Blaser Brian J.Executive Vice President
|
GrantOption (right to buy) · Derivative | 356,735 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019917 · edgar.xml · derivative · entry 2 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,735 Underlying: Common shares · 356,735 shares Expires 2026-02-18 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 118,912 on 02/19/2017, 118,911 on 02/19/2018, and 118,912 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:02 UTC |
Blaser Brian J.Executive Vice President
|
GrantCommon shares without par value | 40,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019917 · edgar.xml · nonDerivative · entry 1 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,884 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.